Maneesh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 28.13 Cr
as on 07-07-2024
- Company Age 39 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.00 Cr
as on 07-07-2024
- Satisfied Charges ₹ 1,045.43 Cr
as on 07-07-2024
- Revenue -0.63%
(FY 2021)
- Profit -123.78%
(FY 2021)
- Ebitda -1.55%
(FY 2021)
- Net Worth -7.14%
(FY 2021)
- Total Assets -15.94%
(FY 2021)
About Maneesh Pharmaceuticals
The Corporate was formerly known as Maneesh Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 28.13 Cr.
The company currently has active open charges totaling ₹18.00 Cr. The company has closed loans amounting to ₹1,045.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Maneesh Pharmaceuticals Limited India are Rakesh Tunaram as CFO and Chetan Chandwani as Company Secretary. Maneesh Sapte, Vinay Sapte, Rashmi Sapte, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1985PLC036952
- Company No.
036952
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Jul 1985
- Date of AGM
11 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maneesh Pharmaceuticals Limited offer?
Maneesh Pharmaceuticals Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Immunomodulator Drugs, Common Disease Medicines, Injectable Products, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Muscle Relaxant, Drotaverine Hydrochloride Mefenamic Acid Tablet, Antidepressant & Anti Anxiety Medicines, Psychotherapeutic Agents.
Who are the key members and board of directors at Maneesh Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Tunaram  | CFO | Current | |
| Chetan Chandwani | Company Secretary | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maneesh Sapte | Whole-Time Director | 01-Oct-2002 | Current |
| Vinay Sapte | Director | 25-Jul-1985 | Current |
| Rashmi Sapte | Director | 30-Mar-2007 | Current |
| Pravin Hegde | Director | 01-Mar-2007 | Current |
| Ajit Jamkhandikar | Director | 24-Aug-2018 | Current |
Financial Performance and Corporate Structure Insights of Maneesh Pharmaceuticals.
Maneesh Pharmaceuticals Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 0.63% decrease. The company also saw a substantial fall in profitability, with a 123.78% decrease in profit. The company's net worth dipped by a decrease of 7.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maneesh Pharmaceuticals?
In 2023, Maneesh Pharmaceuticals had a promoter holding of 70.63% and a public holding of 29.36%. The company had 5 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ergos Life Sciences Private LimitedActive 7 years 9 monthsVinay Sapte and Chetan Chandwani are mutual person
- Pharmanova Specialties Private LimitedActive 10 years 10 months
Maneesh Sapte and Vinay Sapte are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Export-Import Bank Of India Creation Date: 19 Jul 2004 | ₹18.00 Cr | Open |
Pegasus Group Twenty Six Trust - I- Pegasus Assets Reconstruction Private Limited Creation Date: 28 Dec 2011 | ₹110.58 Cr | Satisfied |
Icici Bank Limited Creation Date: 18 Feb 2011 | ₹18.50 Cr | Satisfied |
How Many Employees Work at Maneesh Pharmaceuticals?
Maneesh Pharmaceuticals has a workforce of 1219 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maneesh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maneesh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
